Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Neutropenia
Interventions: BIOLOGICAL: Balugrastim|DRUG: Pegfilgrastim|DRUG: Chemotherapy Regimen
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.